English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [998]
News [2138]
Articles [118]
Editorials [8]
Conferences [84]
elearning [10]
Neuronal molecule makes prostate cancer more aggressive
Neuronal molecule makes prostate cancer more aggressive
National prostate cancer trial testing therapy based on molecular discovery
National prostate cancer trial testing therapy based on molecular discovery
MRI-guided radiotherapy produces fewer side effects and better quality of life for patients with localised prostate cancer
MRI-guided radiotherapy produces fewer side effects and better quality of life for patients with localised...
New hormonal agent may slow progression of early-stage prostate cancer during active surveillance
New hormonal agent may slow progression of early-stage prostate cancer during active surveillance
Experts explain treatment options for a common cancer complication
Experts explain treatment options for a common cancer complication
FDA approves first adenoviral vector-based gene therapy for high-risk Bacillus Calmette-Guérin unresponsive non-muscle invasive bladder cancer
FDA approves first adenoviral vector-based gene therapy for high-risk Bacillus Calmette-Guérin unresponsive non...
Exercise is medicine for cancer and every dose counts - even in late stages in the disease
Exercise is medicine for cancer and every dose counts - even in late stages in the disease
New prostate cancer diagnostic pathway paves way for general screening
New prostate cancer diagnostic pathway paves way for general screening
Hospital parking fees contribute to financial toxicity for cancer patients
Hospital parking fees contribute to financial toxicity for cancer patients
Darolutamide + ADT in combination with docetaxel licenced by MHRA and made immediately available through NHS England early access deal for the treatment of patients with mHSPC
Darolutamide + ADT in combination with docetaxel licenced by MHRA and made immediately available through NHS...
<123456...214>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2023 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top